CAS: 25301-02-4; Formaldehyde,Oxirane,4-(2,4,4-Trimethylpentan-2-yl)Phenol

该化合物是一种合成聚合物,其独特结构是将环氧乙烷和甲丁二烯与苯丙胺结合的,这种合成聚合物具有极强的热稳定性和化学抗药性,适合各种工业应用,包括涂层,粘合剂和密封剂;其苯丙基成分有助于提高机械特性和耐久性,而环氧乙烷部分则具有灵活性和水利性;四甲基丁基聚物组的存在增强了共聚物对环境退化的抗药性,提高了其与其他材料的兼容性;此外,这种共聚物可产生低毒性,并经常用于需要生物兼容性的配方.

结构式图片

欧盟法规

C&L通报

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2012190064-A1
    优先权日:2004-10-01
    标题 :Feeding buffers, systems, and methods for in vitro synthesis of biomolecules
    发明人:KUDLICKI WIESLAW ANTONI; KEPPETIPOLA SHIRANTHI; FLETCHER JULIA; GETBEHEAD ASHLEY ELAINE; KATZEN FEDERICO; VOZZA-BROWN LAURA
    权利人:KUDLICKI WIESLAW ANTONI; KEPPETIPOLA SHIRANTHI; FLETCHER JULIA; GETBEHEAD ASHLEY ELAINE; KATZEN FEDERICO; VOZZA-BROWN LAURA; LIFE TECHNOLOGIES CORP
    摘要:Compositions, methods and kits for in vitro systems for synthesis of biomolecules such as polypeptides, are provided herein. Cell extracts that provide enhanced yields of soluble proteins using in vitro protein synthesis methods are provided. The invention also includes methods for producing high yields of proteins by the addition of a feeding solution that includes amino acids and an energy source to an ongoing in vitro synthesis system. The invention also includes methods of using a high-yield in vitro synthesis system to produce large quantities of proteins with incorporated labeled amino acids for analysis by methods such as by NMR. The invention further includes vectors for enhanced production of proteins from nucleic acid templates using in vitro synthesis systems.

    专利号:US-2008107683-A1
    优先权日:2004-11-30
    标题 :Bacterial Packaging Strains Useful for Generation and Production of Recombinant Double-Stranded RNA Nucleocapsids and Uses Thereof
    发明人:HONE DAVID; FULKERSON JOHN; SADOFF JERALD C; ONYABE DAVID; STONE MICHELE
    权利人:HONE DAVID; FULKERSON JOHN; SADOFF JERALD C; ONYABE DAVID; STONE MICHELE
    摘要:Bacterial packaging strains useful for generating recombinant double-stranded RNA nucleocapsids (rdsRNs) are provided. The packaging strains are useful for the production of RNA encoding vaccine antigens, bioactive proteins, immunoregulatory proteins, antisense RNAs, and catalytic RNAs in eukaryotic cells or tissues. Recombinant ssRNA is introduced into the strains and packaged to form rdsRNs de novo. The packaging strains and rdsRNs may also comprise nucleic acid sequences that stabilize a closed loop eukaryotic translation complex; nucleic acid sequences encoding one or more proteins that interfere with a host cell type I interferon (IFN) response; as well as recombinant alphavirus replicons encoding a protein complex specific for plus strand RNA-dependent synthesis of minus strand RNA

    专利号:US-7659106-B2
    优先权日:1998-10-09
    标 题:Non-homogeneous systems for the resolution of enantiomeric mixtures
    发明人:ALMOND MERRICK R; FONG WANG YI; YIMING YAO
    权利人:ALTUS PHARMACEUTICALS INC; GILEAD SCIENCES INC
    摘要:The present invention relates to a process for the biocatalyst-mediated enantioselective conversion of enantiomeric mixtures of hydrophobic esters using a biphasic solvent system. More particularly, the present invention relates to the enzyme-mediated enantioselective synthesis of anti-viral compounds, such as 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane (FTC) and its analogues, in a non-homogenous reaction system.

    专利号:US-11180480-B2
    优先权日:2017-10-17
    标题:Synthesis of 4-aminopyrimidine compounds
    发明人:COPMANS DAAN; MOHR AMANDINE; BONTEN MAURICE HUBERT; TORONTO DAWN
    权利人:SENSORION
    摘要:A process for manufacturing 2-isobutyl-6-(3-(methylamino)azetidin-1-yl)pyrimidin-4-amine of Formula (I):including starting from 6-chloro-2-isobutylpyrimidin-4-amine and tert-butyl azetidin-3-yl(methyl)carbamate, or another N-protected N-methylazetidin-3-amine, and performing the following steps: (a) coupling reaction of both compounds in dimethylsulfoxide in presence of potassium carbonate to afford an intermediate protected compound; and (b) deprotection of the protected compound to afford 2-isobutyl-6-(3-(methylamino)azetidin-1-yl)pyrimidin-4-amine. Also, a process for manufacturing the intermediate protected compound, wherein deprotection step (b) is omitted, and the compounds obtained from the processes.

    专利号:US-5656634-A
    优先权日:1991-03-21
    标题 :N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)
    发明人:CHANG GEORGE; HAMANAKA ERNEST S; MCCARTHY PETER A; TRUONG THIEN V; WALKER FREDERICK J
    权利人:PFIZER
    摘要:Compounds of the formula ##STR1## the pharmaceutically acceptable salts thereof, wherein Q and R 1 are as defined below, and novel carboxylic acid and acid halide intermediates used in the synthesis of such compounds. The compounds of formula I are inhibitors of acyl coenzyme A: cholesterol acyltransferase (ACAT) and are useful as hypolipidemic and antiatherosclerosis agents.

    专利号:EP-1119635-B1
    优先权日:1998-10-09
    标 题 :Non-homogeneous systems for the resolution of enantiomeric mixtures
    发明人:YAO YIMING; WANG YI FONG; ALMOND MERRICK R
    权利人:ALTHEA TECHNOLOGIES INC; GILEAD SCIENCES INC
    摘要:The present invention relates to a process for the biocatalyst-mediated enantioselective conversion of enantiomeric mixtures of hydrophobic esters using a biphasic solvent system. More particularly, the present invention relates to the enzyme-mediated enantioselective synthesis of anti-viral compounds, such as 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane (FTC) and its analogues, in a non-homogeneous reaction system.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Compound: Ethylene oxide-formaldehyde-4-(1,1,3,3-tetramethylbutyl)phenol copolymer
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知